Investors Buy Shares of Baker Hughes (BHGE) on Weakness
Traders bought shares of Baker Hughes Incorporated (NYSE:BHGE) on weakness during trading hours on Wednesday. $60.61 million flowed into the stock on the tick-up and $16.62 million flowed out of the stock on the tick-down, for a money net flow of $43.99 million into the stock. Of all companies tracked, Baker Hughes had the 6th highest net in-flow for the day. Baker Hughes traded down ($0.62) for the day and closed at $30.33
BHGE has been the subject of several analyst reports. Zacks Investment Research raised Baker Hughes from a “strong sell” rating to a “hold” rating in a report on Monday, November 13th. B. Riley reissued a “neutral” rating on shares of Baker Hughes in a report on Friday, November 3rd. Barclays set a $41.00 price objective on Baker Hughes and gave the company a “buy” rating in a report on Thursday, October 26th. Citigroup cut their price target on Baker Hughes from $44.00 to $41.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Finally, Royal Bank of Canada set a $38.00 price target on Baker Hughes and gave the company an “outperform” rating in a research note on Wednesday, October 25th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $40.74.
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.29 and a current ratio of 1.90.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 22nd. Investors of record on Monday, November 6th were issued a $0.18 dividend. The ex-dividend date was Friday, November 3rd. This is a boost from Baker Hughes’s previous quarterly dividend of $0.17. This represents a $0.72 dividend on an annualized basis and a yield of 2.37%. Baker Hughes’s dividend payout ratio is currently -111.34%.
In other Baker Hughes news, insider Matthias L. Heilmann acquired 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The shares were purchased at an average cost of $30.04 per share, for a total transaction of $45,060.00. Following the completion of the acquisition, the insider now owns 3,500 shares of the company’s stock, valued at approximately $105,140. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.66% of the company’s stock.
A number of large investors have recently bought and sold shares of the stock. First Bank & Trust purchased a new position in Baker Hughes in the third quarter valued at $101,000. Amica Retiree Medical Trust purchased a new position in Baker Hughes in the third quarter valued at $101,000. Trust Co. of Vermont purchased a new position in shares of Baker Hughes during the third quarter worth about $105,000. Westside Investment Management Inc. purchased a new position in shares of Baker Hughes during the third quarter worth about $108,000. Finally, Sun Life Financial INC purchased a new position in shares of Baker Hughes during the third quarter worth about $115,000. 89.48% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/investors-buy-shares-of-baker-hughes-bhge-on-weakness-2/1762306.html.
Receive News & Ratings for Baker Hughes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baker Hughes and related companies with MarketBeat.com's FREE daily email newsletter.